Fuji Pharma Co., Ltd. (4554.T)
JPY 1536.0
(0.26%)
JPY 1536.0
(0.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 28.94 Billion JPY | 17.82% |
| 2022 | 24.56 Billion JPY | 31.65% |
| 2021 | 18.66 Billion JPY | 53.09% |
| 2020 | 12.19 Billion JPY | 11.69% |
| 2019 | 10.91 Billion JPY | 115.22% |
| 2018 | 5.07 Billion JPY | 4.23% |
| 2017 | 4.86 Billion JPY | -29.53% |
| 2016 | 6.9 Billion JPY | 17.26% |
| 2015 | 5.88 Billion JPY | -29.35% |
| 2014 | 8.33 Billion JPY | 32.9% |
| 2013 | 6.27 Billion JPY | 261.07% |
| 2012 | 1.73 Billion JPY | -4.68% |
| 2011 | 1.82 Billion JPY | 228.93% |
| 2010 | 553.92 Million JPY | 8.56% |
| 2009 | 510.24 Million JPY | 15.07% |
| 2008 | 443.4 Million JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 27.3 Billion JPY | -0.23% |
| 2024 Q1 | 27.37 Billion JPY | -5.45% |
| 2024 Q3 | 22.58 Billion JPY | 5.79% |
| 2023 Q2 | 29.68 Billion JPY | -0.68% |
| 2023 Q4 | 28.94 Billion JPY | -2.47% |
| 2023 FY | 28.94 Billion JPY | 17.82% |
| 2023 Q1 | 29.88 Billion JPY | 21.64% |
| 2023 Q3 | 29.68 Billion JPY | -0.0% |
| 2022 Q3 | 25.34 Billion JPY | -2.86% |
| 2022 Q1 | 18.06 Billion JPY | -3.22% |
| 2022 Q2 | 26.08 Billion JPY | 44.44% |
| 2022 FY | 24.56 Billion JPY | 31.65% |
| 2022 Q4 | 24.56 Billion JPY | -3.05% |
| 2021 Q3 | 17.83 Billion JPY | -3.35% |
| 2021 Q1 | 11.67 Billion JPY | -4.19% |
| 2021 FY | 18.66 Billion JPY | 53.09% |
| 2021 Q4 | 18.66 Billion JPY | 4.65% |
| 2021 Q2 | 18.45 Billion JPY | 57.98% |
| 2020 FY | 12.19 Billion JPY | 11.69% |
| 2020 Q2 | 8.17 Billion JPY | -5.11% |
| 2020 Q3 | 12.78 Billion JPY | 56.37% |
| 2020 Q1 | 8.61 Billion JPY | -21.08% |
| 2020 Q4 | 12.19 Billion JPY | -4.62% |
| 2019 Q2 | 11.58 Billion JPY | 136.37% |
| 2019 Q3 | 11.24 Billion JPY | -2.94% |
| 2019 Q4 | 10.91 Billion JPY | -2.95% |
| 2019 FY | 10.91 Billion JPY | 115.22% |
| 2019 Q1 | 4.9 Billion JPY | -3.33% |
| 2018 FY | 5.07 Billion JPY | 4.23% |
| 2018 Q4 | 5.07 Billion JPY | -1.05% |
| 2018 Q3 | 5.12 Billion JPY | -2.81% |
| 2018 Q2 | 5.27 Billion JPY | -12.09% |
| 2018 Q1 | 5.99 Billion JPY | 23.29% |
| 2017 Q2 | 5.52 Billion JPY | -21.2% |
| 2017 Q1 | 7.01 Billion JPY | 1.54% |
| 2017 FY | 4.86 Billion JPY | -29.53% |
| 2017 Q4 | 4.86 Billion JPY | -9.07% |
| 2017 Q3 | 5.35 Billion JPY | -3.15% |
| 2016 Q1 | 7.73 Billion JPY | 31.28% |
| 2016 FY | 6.9 Billion JPY | 17.26% |
| 2016 Q3 | 7.16 Billion JPY | -1.39% |
| 2016 Q4 | 6.9 Billion JPY | -3.59% |
| 2016 Q2 | 7.26 Billion JPY | -6.05% |
| 2015 Q3 | 6.35 Billion JPY | -6.84% |
| 2015 Q2 | 6.82 Billion JPY | -2.36% |
| 2015 Q1 | 6.99 Billion JPY | -16.13% |
| 2015 FY | 5.88 Billion JPY | -29.35% |
| 2015 Q4 | 5.88 Billion JPY | -7.39% |
| 2014 Q2 | 5.82 Billion JPY | -7.21% |
| 2014 Q1 | 6.28 Billion JPY | 0.18% |
| 2014 FY | 8.33 Billion JPY | 32.9% |
| 2014 Q3 | 5.73 Billion JPY | -1.65% |
| 2014 Q4 | 8.33 Billion JPY | 45.37% |
| 2013 FY | 6.27 Billion JPY | 261.07% |
| 2013 Q1 | 5.91 Billion JPY | 240.51% |
| 2013 Q4 | 6.27 Billion JPY | -5.94% |
| 2013 Q2 | 6.83 Billion JPY | 15.57% |
| 2013 Q3 | 6.66 Billion JPY | -2.46% |
| 2012 FY | 1.73 Billion JPY | -4.68% |
| 2012 Q4 | 1.73 Billion JPY | 73.68% |
| 2012 Q3 | 1 Billion JPY | 0.0% |
| 2012 Q2 | 1 Billion JPY | -23.08% |
| 2012 Q1 | 1.3 Billion JPY | -28.65% |
| 2011 FY | 1.82 Billion JPY | 228.93% |
| 2011 Q3 | 1.4 Billion JPY | 0.0% |
| 2011 Q1 | 1.3 Billion JPY | 134.69% |
| 2011 Q4 | 1.82 Billion JPY | 30.14% |
| 2011 Q2 | 1.4 Billion JPY | 7.69% |
| 2010 Q3 | - JPY | 0.0% |
| 2010 Q1 | - JPY | -100.0% |
| 2010 Q2 | - JPY | 0.0% |
| 2010 FY | 553.92 Million JPY | 8.56% |
| 2010 Q4 | 553.92 Million JPY | 0.0% |
| 2009 Q2 | - JPY | 0.0% |
| 2009 Q1 | - JPY | 0.0% |
| 2009 Q4 | 510.24 Million JPY | 0.0% |
| 2009 FY | 510.24 Million JPY | 15.07% |
| 2008 FY | 443.4 Million JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 16.89 Billion JPY | -71.381% |
| Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.402% |
| Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 93.089% |
| Shionogi & Co., Ltd. | 11.62 Billion JPY | -149.122% |
| Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -28695.671% |
| Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -907.939% |
| Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -651.896% |
| Eisai Co., Ltd. | 206.74 Billion JPY | 85.998% |
| Morishita Jintan Co., Ltd. | 425 Million JPY | -6711.294% |
| Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -1278.476% |
| Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -7744.986% |
| Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | -127.543% |
| Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | -70.473% |
| Tsumura & Co. | 79.69 Billion JPY | 63.674% |
| Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -1576.202% |
| Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -11763.934% |
| Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 85.695% |
| Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | 39.167% |
| KYORIN Holdings, Inc. | 20.94 Billion JPY | -38.203% |
| Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -659.989% |
| Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -232.011% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 60 Million JPY | -48146.667% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -6917.697% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -205.198% |
| Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 65.077% |
| Cyfuse Biomedical K.K. | 913 Million JPY | -3070.646% |
| Toho Holdings Co., Ltd. | 30.24 Billion JPY | 4.285% |
| Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -924.604% |